2023-12-20 07:46:03
Zurich (awp) – The Swiss Stock Exchange should once once more start the session on the right foot on Wednesday, like the previous days, despite a slightly lower close on Tuesday. A drop that investors should quickly forget, while on Wall Street, the Dow Jones index ended on a new record, even if the day was sorely lacking in momentum, with the approach of the end-of-year holidays.
Referring to the good performance of one of the key American indices, John Plassard, of Mirabaud Banque, wonders in his commentary: “end-of-year euphoria, enhancement of portfolios or magic of Christmas?”
In today’s macroeconomic news, Japan’s exports fell slightly in November. The decline, the first in three months, confirms the difficulties of economic recovery in the archipelago whose gross domestic product (GDP) shrank in the third quarter. Japanese deliveries fell last month by 0.2% year-on-year.
For the rest of the day, the markets will focus their attention on inflation and producer prices for November in Great Britain as well as on consumer confidence for January in Germany.
Around 8:11 a.m. on the Swiss Stock Exchange, the SMI was up 0.14% at 11,161.82 points, according to pre-market calculations by the Julius Bär bank. All of the twenty stocks making up the flagship index of the Swiss market rose, within a range of 0.7 to 0.1%.
At the top of the table, UBS (+0.7%) continued the momentum of the day before, the title of the number one Swiss bank having jumped by more than 3%, thanks to the entry into its share capital of the fund Swedish investment company Cevian. The bank with three keys largely escaped ahead of ABB (+0.1%) and Richemont (+0.1%) as well as all the other stocks of the SMI, the defensive Swisscom (+0.07%) inheriting for its part of the red lantern.
Excluding SMI, DocMorris took off by 2.1%, just like VAT Group. The St. Gallen specialist in vacuum pumps benefited from the raising of Baader Helvea’s recommendation to “add”, once morest “reduce” previously and from the price target to 444 Swiss francs, once morest 259 Swiss francs. Inficon, on the other hand, fell by 2.9%, the same Baader Helvea having revised downwards its recommendation of the stock from “add” to “reduce”, while the price target was raised to 1180 Swiss francs, once morest 900 francs Swiss until then.
vj/lk
1703060286
#Zurich #Stock #Exchange #expected #opening #December
